title: Recurrence of clonal hematopoiesis after discontinuing pegylated recombinant interferon-alpha 2a in a patient with polycythemia vera.
authors.forename: T
authors.initials: T
authors.lastname: Ishii
authors.forename: M
authors.initials: M
authors.lastname: Xu
authors.forename: Y
authors.initials: Y
authors.lastname: Zhao
authors.forename: W-Y
authors.initials: WY
authors.lastname: Hu
authors.forename: S
authors.initials: S
authors.lastname: Ciurea
authors.forename: E
authors.initials: E
authors.lastname: Bruno
authors.forename: R
authors.initials: R
authors.lastname: Hoffman
mesh_terms: D019943:Amino Acid Substitution; D005260:Female; D006410:Hematopoiesis; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D053614:Janus Kinase 2 / Q000235:genetics; D011087:Polycythemia Vera / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C507924:JAK2 protein, human; D053614:Janus Kinase 2; C100416:peginterferon alfa-2a